U-Blot® Research Grade Anti-Human MAPT/Tau/PHF-tau (CBTAU-24.1)Cat. No. WA2104$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human MAPT/Tau/PHF-tau (CBTAU-24.1)Cat. No. WA2104
U-Blot® Research Grade Anti-Human MAPT/Tau/PHF-tau (BIIB076)Cat. No. WA2103
U-Blot® Research Grade Anti-Human MAPT/Tau/PHF-tau (APNmAb005)Cat. No. WA2102
U-Blot® Research Grade Anti-Human MAGEA4 Antibody (Imc-C103C)Cat. No. WA2101
U-Blot® Research Grade Anti-Human LY6G6D/MEGT1 Antibody (20A12.QNTv12)Cat. No. WA2100
U-Blot® Research Grade Anti-Human LY6G6D/MEGT1 (1G4)Cat. No. WA2099
U-Blot® Research Grade Anti-Human LY6E/SCA-2 Antibody (Hu9B12v12)Cat. No. WA2098
U-Blot® Research Grade Anti-Human LY6E/SCA-2 (RG 7841)Cat. No. WA2097
U-Blot® Research Grade Anti-Human LTBR/TNFR-III Antibody (CBE-11)Cat. No. WA2096
U-Blot® Research Grade Anti-Human LRP6 (GSK3178022)Cat. No. WA2095
U-Blot® Research Grade Anti-Human LIF (MSC-1)Cat. No. WA2094
U-Blot® Research Grade Anti-Human LGR5/GPR49 Antibody (18G7H6A3)Cat. No. WA2093